De novo homozygous variant of the SCN1A gene in a patient with severe Dravet syndrome complicated by acute encephalopathy

Neurogenetics. 2021 May;22(2):133-136. doi: 10.1007/s10048-021-00636-7. Epub 2021 Mar 5.

Abstract

Variants in the SCN1A gene have been identified in epilepsy patients with widely variable phenotypes and they are generally heterozygous. Here, we report a homozygous missense variant, NM_001165963.4: c.4319C>T (p.Ala1440Val), in the SCN1A gene which seemed to occur de novo together with a gene conversion event. It's highly possible that this variant, although located in a critical functional domain of protein Nav1.1, depending on the nature of the amino acid substitution, may not cause the complete loss of protein function. And the accumulated effect by having this variant on both alleles results in a Dravet syndrome phenotype which is more severe than average. This first report of a de novo homozygous variant in the SCN1A gene, therefore, provides a clear illustration of a complex genotype-phenotype relationship.

Keywords: Acute encephalopathy; De novo; Dravet syndrome; Homozygous; SCN1A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Autism Spectrum Disorder / genetics
  • Brain Diseases / etiology*
  • Child Behavior Disorders / genetics
  • Drug Resistant Epilepsy / genetics
  • Epilepsies, Myoclonic / complications
  • Epilepsies, Myoclonic / genetics*
  • Genetic Association Studies
  • Homozygote
  • Humans
  • Infant
  • Male
  • Mutation, Missense*
  • NAV1.1 Voltage-Gated Sodium Channel / genetics*
  • Point Mutation*
  • Protein Domains / genetics
  • Sleep Wake Disorders / genetics

Substances

  • NAV1.1 Voltage-Gated Sodium Channel
  • SCN1A protein, human